Patienterne skal være under opsyn af medicinsk personale i mindst tre timer efter injektionen, og de skal derfor behandles med Zypadhera på en klinik med tilstrækkelige faciliteter til at behandle en eventuel overdosis.
Because patients should be monitored by qualified staff for these symptoms for at least three hours after injection, they should receive Zypadhera at a centre with the appropriate facilities to deal with a potential overdose.